pain neuropathy

There is a clinical study available, seeking participants who have Breast Cancer in order evaluate whether the study drug combined with hormonal therapy has better outcomes than hormonal therapy alone.

More about the study:

• The investigational drug is administered by oral capsules and the hormonal therapy by injection into your muscle
• At least 193 people have already taken this drug in clinical trials
• There will be 550 participants in this trial

If you are interested, the full study details and eligibility criteria are listed here.

Eligibility Criteria:

Participants must:

• have been diagnosed with breast cancer which expresses at least one hormone receptor (estrogen receptor or progesterone receptor) and is HER2 negative
• have stopped having monthly menstrual cycles either naturally or through surgery or hormonal treatment

Participants must not:

• have received chemotherapy for metastatic disease (neoadjuvant and adjuvant chemotherapy is allowed)
• be currently participating in any other clinical trial
• have a history of central nervous system metastases

Please complete the online questionnaire to check if you’re eligible for the trial.

If you’re not familiar with clinical trials, here are some FAQs:

What are clinical trials?

Clinical trials are research studies to determine whether investigational drugs or treatments are safe and effective for humans. All new investigational medications and devices must undergo several clinical trials, often involving thousands of people.

Why participate in a clinical trial?

You will have access to new investigational treatments that would be available to the general public only upon approval. You will also receive study-related medical care and attention from clinical trial staff at research facilities. Clinical trials offer hope for many people and an opportunity to help researchers find better treatments for others in the future.

Learn why I’m talking about Clinical Trials